Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer

Cancer Cell International

Volumn 14, Issue 1, 2014, Pages

  Shi, Rong ^a   Zhao, Zhen ^a   Zhou, Hui ^a   Wei, Min ^a   Ma, Wen Li ^a   Zhou, Jue Yu ^a   Tan, Wan Long ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; PinX1; Prostate cancer; Tissue microarray

Indexed keywords

BINDING PROTEIN; MESSENGER RNA; PIN2 TRF1 BINDING PROTEIN X1; TELOMERIC REPEAT BINDING FACTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISTANT METASTASIS; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; WESTERN BLOTTING;

EID: 84902551761     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-14-46     Document Type: Article

References (24)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
2. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012, 61(6):1079-1092. 10.1016/j.eururo.2012.02.054, 22424666.
3. Briganti A, Suardi N, Gallina A, Abdollah F, Novara G, Ficarra V, Montorsi F. Predicting the risk of bone metastasis in prostate cancer. Cancer Treat Rev 2014, 40(1):3-11. 10.1016/j.ctrv.2013.07.001, 23896177.
4. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL. Metastatic patterns in adenocarcinoma. Cancer 2006, 106(7):1624-1633. 10.1002/cncr.21778, 16518827.
5. Hudson BD, Kulp KS, Loots GG. Prostate cancer invasion and metastasis: insights from mining genomic data. Brief Funct Genomics 2013, 12(5):397-410. 10.1093/bfgp/elt021, 23878130.
6. Zhou XZ, Lu KP. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 2001, 107(3):347-359. 10.1016/S0092-8674(01)00538-4, 11701125.
7. Zhou XZ, Huang P, Shi R, Lee TH, Lu G, Zhang Z, Bronson R, Lu KP. The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice. J Clin Invest 2011, 121(4):1266-1282. 10.1172/JCI43452, 3069765, 21436583.
8. Zhou XZ. PinX1: a sought-after major tumor suppressor at human chromosome 8p23. Oncotarget 2011, 2(10):810-819. 3248153, 22021332.
9. Cai MY, Zhang B, He WP, Yang GF, Rao HL, Rao ZY, Wu QL, Guan XY, Kung HF, Zeng YX, Xie D. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci 2010, 101(6):1543-1549. 10.1111/j.1349-7006.2010.01560.x, 20367640.
10. Kondo T, Oue N, Mitani Y, Kuniyasu H, Noguchi T, Kuraoka K, Nakayama H, Yasui W. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene 2005, 24(1):157-164. 10.1038/sj.onc.1207832, 15637589.
11. Ma Y, Wu L, Liu C, Xu L, Li D, Li JC. The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population. J Cancer Res Clin Oncol 2009, 135(3):431-437. 10.1007/s00432-008-0471-6, 18784941.
12. Park WS, Lee JH, Park JY, Jeong SW, Shin MS, Kim HS, Lee SK, Lee SN, Lee SH, Park CG, Yoo NJ, Lee JY. Genetic analysis of the liver putative tumor suppressor (LPTS) gene in hepatocellular carcinomas. Cancer Lett 2002, 178(2):199-207. 10.1016/S0304-3835(01)00841-2, 11867205.
13. Lai XF, Shen CX, Wen Z, Qian YH, Yu CS, Wang JQ, Zhong PN, Wang HL. PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells. J Exp Clin Cancer Res 2012, 31:12. 10.1186/1756-9966-31-12, 3296635, 22316341.
14. Chen G, Da L, Wang H, Xu Y, Sun C, Wang L, Zhao J, Zhang F, Feng J, Wang Y, Tiollais P, Li T, Zhao M. HIV-Tat-mediated delivery of an LPTS functional fragment inhibits telomerase activity and tumorigenicity of hepatoma cells. Gastroenterology 2011, 140(1):332-343. 10.1053/j.gastro.2010.08.046, 20816839.
15. Zhang L, Jiang Y, Zheng Y, Zeng Y, Yang Z, Huang G, Liu D, Gao M, Shen X, Wu G, Yan X, He F. Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1. Leukemia 2011, 25(2):331-340. 10.1038/leu.2010.261, 3049869, 21102426.
16. Wang HB, Wang XW, Zhou G, Wang WQ, Sun YG, Yang SM, Fang DC. PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway. J Gastrointest Surg 2010, 14(8):1227-1234. 10.1007/s11605-010-1253-4, 20544396.
17. Wang HB, Wang WQ, Wang XW, Sun YG, Zhou G, Yang SM, Fan DC. PinX1 gene transfection enhances the sensitivity of gastric carcinoma cell line to 5-fluorouracil. Hepatogastroenterology 2011, 58(106):682-686.
18. Zuo J, Wang DH, Zhang YJ, Liu L, Liu FL, Liu W. Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells. Oncol Rep 2013, 30(4):1823-1831.
19. Dijkstra S, Mulders PF, Schalken JA. Clinical Use of Novel Urine and Blood Based Prostate Cancer Biomarkers: a review. Clin Biochem 2013, doi:10.1016/j.clinbiochem.2013.10.023.
20. Khatami A, Hugosson J, Wang W, Damber JE. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy. Scand J Urol Nephrol 2009, 43(1):12-18. 10.1080/00365590802469543, 18949633.
21. Bhalla R, Kunju LP, Tomlins SA, Christopherson K, Cortez C, Carskadon S, Siddiqui J, Park K, Mosquera JM, Pestano GA, Rubin MA, Chinnaiyan AM, Palanisamy N. Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma. Mod Pathol 2013, 26(6):835-848. 10.1038/modpathol.2012.234, 3672354, 23348902.
22. Cooperberg MR, Simko JP, Cowan JE, Reid JE, Djalilvand A, Bhatnagar S, Gutin A, Lanchbury JS, Swanson GP, Stone S, Carroll PR. Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol 2013, 31(11):1428-1434. 10.1200/JCO.2012.46.4396, 23460710.
23. Taneja SS. Re: Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Urol 2013, 190(4):1245.
24. Soohoo CY, Shi R, Lee TH, Huang P, Lu KP, Zhou XZ. Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation. J Biol Chem 2011, 286(5):3894-3906. 10.1074/jbc.M110.180174, 3030390, 21119197.